Skip to Main Content

Author Details

Xiaolong Cui
First Hospital of ShanXi Medical University
2008
35
18
PMIDPaper TitleJournal TitlePublished Year
32898433Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.Cancer Biother Radiopharm2023
37478845A lncRNA from the FTO locus acts as a suppressor of the m<sup>6</sup>A writer complex and p53 tumor suppression signaling.Mol Cell2023
37387525PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines.Database (Oxford)2023
37387524PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines.Database (Oxford)2023
35033535The METTL5-TRMT112 N<sup>6</sup>-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.J Biol Chem2022
35511947FTO mediates LINE1 m[6]A demethylation and chromatin regulation in mESCs and mouse development.Science2022
35814400Gene Mutational Clusters in the Tumors of Colorectal Cancer Patients With a Family History of Cancer.Front Oncol2022
36461076METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets.Genome Biol2022
36075114Low expression of lncRNA APTR promotes gastric cancer progression.Transl Oncol2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
33416181lncRNA TUSC7 inhibits osteosarcoma progression through the miRâ¿¿181a/RASSF6 axis.Int J Mol Med2021
33574286Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma.NPJ Genom Med2021
33570926Correction to "DNA 5-Methylcytosine-Specific Amplification and Sequencing".J Am Chem Soc2021
33846348Autophagy of the m[6]A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.Nat Commun2021
34452996METTL14 facilitates global genome repair and suppresses skin tumorigenesis.Proc Natl Acad Sci U S A2021
34650683Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17.Am J Transl Res2021
34676872Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β⿿catenin.Mol Med Rep2021
34151267An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas.Neurooncol Adv2021
34048572Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.Nucleic Acids Res2021
32341503A metabolic labeling method detects m<sup>6</sup>A transcriptome-wide at single base resolution.Nat Chem Biol2020
32077696DNA 5-Methylcytosine-Specific Amplification and Sequencing.J Am Chem Soc2020
33033384Author Correction: An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease.Nat Genet2020
33268789A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation.Nat Commun2020
32989324An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease.Nat Genet2020
32610122Control of Early B Cell Development by the RNA N<sup>6</sup>-Methyladenosine Methylation.Cell Rep2020
32183942N<sup>6</sup>-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA.Mol Cell2020
31117646Jump-seq: Genome-Wide Capture and Amplification of 5-Hydroxymethylcytosine Sites.J Am Chem Soc2019
31548705Evolution of a reverse transcriptase to map N<sup>1</sup>-methyladenosine in human messenger RNA.Nat Methods2019
29426862Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2018
30197295Differential m<sup>6</sup>A, m<sup>6</sup>A<sub>m</sub>, and m<sup>1</sup>A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm.Mol Cell2018
30325306OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development.Elife2018
29507755VIRMA mediates preferential m<sup>6</sup>A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.Cell Discov2018
29235481Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.Nat Commun2017
25098760Collagen scaffolds combined with collagen-binding ciliary neurotrophic factor facilitate facial nerve repair in mini-pigs.J Biomed Mater Res A2015
18830344Second-order oriented partial-differential equations for denoising in electronic-speckle-pattern interferometry fringes.Opt Lett2008
  • 1 - 35 of 35

Recommended Authors

Li Chen
Indiana University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Hailiang Mei
Leiden University Medical Center
Career Start Year 2014
Number of shared co-authors 0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 2
Yibu Chen
USC Libraries Bioinformatic Services of the University of Southern California
Career Start Year 2012
Number of shared co-authors 0
Juozas Gordevi??ius
Epigenetic Clock Development Foundation
Career Start Year 2012
Number of shared co-authors 2
Anna R Poetsch
Technical University Dresden
Career Start Year 2009
Number of shared co-authors 0
Brandy Klotzle
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 2
Yunbo Qiao
Guangzhou University
Career Start Year 2009
Number of shared co-authors 0
Chengqi Yi
Peking University
Career Start Year 2008
Number of shared co-authors 2
Dejian Zhao
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Jonathan E Bard
University at Buffalo
Career Start Year 2007
Number of shared co-authors 0
Nongluk Plongthongkum
King Mongkut's University of Technology Thonburi
Career Start Year 2007
Number of shared co-authors 2
Altuna Akalin
Berlin Institute for Medical Systems Biology
Career Start Year 2006
Number of shared co-authors 2
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 1
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Kun Zhang
China Pharmaceutical University
Career Start Year 2005
Number of shared co-authors 2
Chol-Hee Jung
University of Melbourne
Career Start Year 2005
Number of shared co-authors 3
Kun Qu
University of Science and Technology of China
Career Start Year 2005
Number of shared co-authors 1
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 1
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Ting Wang
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 11
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 7
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Howard Y Chang
Center for Personal Dynamic Regulomes, Stanford University
Career Start Year 1992
Number of shared co-authors 6
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 4
Martin J Walsh
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 8
Peter W Laird
Van Andel Institute
Career Start Year 1985
Number of shared co-authors 4
Christoph Plass
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 3

Collaborators

Chuan He
Institute of Hematology, West China Hospital of Sichuan University
Co-authored papers 20
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Greg Donahue
Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Li-San Wang
Co-authored papers 2
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Co-authored papers 2
Anna Bergamaschi
Bluestar Genomics Inc.
Co-authored papers 2
Zhike Lu
Center for Genome Editing
Co-authored papers 2
John Q Trojanowski
University of Pennsylvania
Co-authored papers 2
Lulu Hu
Co-authored papers 2
Simone Sidoli
Co-authored papers 2
Yi Zheng
Children's Hospital Research Foundation
Co-authored papers 2
Benjamin A Garcia
University of Pennsylvania
Co-authored papers 2
Boxuan Simen Zhao
The University of Chicago
Co-authored papers 2
William C Reinhold
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 2
Samuel Levy
Bluestar Genomics Inc.
Co-authored papers 2
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Co-authored papers 2
Martin Sj??str??m
University of California-San Francisco
Co-authored papers 1
Junjie T Hua
School of Public Health, Sun Yat-sen University
Co-authored papers 1
Tierney Phillips
Bluestar Genomics Inc.
Co-authored papers 1
Sarah W S Ng
University of British Columbia
Co-authored papers 1
Paul Lloyd
Bluestar Genomics Inc.
Co-authored papers 1
Erin McCarthy
Bluestar Genomics Inc.
Co-authored papers 1
Eric J Small
University of California san francisco
Co-authored papers 1
Barbara Panning
University of California san francisco
Co-authored papers 1
Arian Lundberg
University of California san francisco
Co-authored papers 1
Martin E Gleave
University of British Columbia
Co-authored papers 1
Kim N Chi
University of British Columbia
Co-authored papers 1
Cameron Herberts
University of British Columbia
Co-authored papers 1
Jianhua Luo
University of Pittsburgh
Co-authored papers 1
Release 1.2